| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors (NCT01873326) | Memorial Sloan Kettering Cancer Center | 2013-06-01 |
| Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma (NCT01892397) | Memorial Sloan Kettering Cancer Center | 2013-06-01 |
| Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies (NCT01877070) | Memorial Sloan Kettering Cancer Center | 2013-06-01 |
| Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment (NCT01888198) | Memorial Sloan Kettering Cancer Center | 2013-06-01 |
| Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma (NCT01866293) | Memorial Sloan Kettering Cancer Center | 2013-05-28 |
| Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins (NCT01872130) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma (NCT01868451) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (NCT01860937) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer (NCT01870505) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation (NCT01856543) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) (NCT01862315) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients (NCT01864083) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma (NCT01864109) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D (NCT01833143) | Memorial Sloan Kettering Cancer Center | 2013-04-11 |
| Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer (NCT01830582) | Memorial Sloan Kettering Cancer Center | 2013-04-09 |
| Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib (NCT01840592) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy (NCT01829958) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma (NCT01828034) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer (NCT01827163) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers (NCT01829984) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation (NCT01836341) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma (NCT01840566) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| A Registry for Patients Treated on the Clinical Trial TAX 3503 (NCT01813370) | Memorial Sloan Kettering Cancer Center | 2013-03-01 |
| ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis (NCT01815359) | Memorial Sloan Kettering Cancer Center | 2013-03-01 |
| Breath Training Exercise for the Reduction of Chronic Dyspnea (NCT01831388) | Memorial Sloan Kettering Cancer Center | 2013-03-01 |
| Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer (NCT01826227) | Memorial Sloan Kettering Cancer Center | 2013-03-01 |
| Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients (NCT01811862) | Memorial Sloan Kettering Cancer Center | 2013-03-01 |
| QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser (NCT01803516) | Memorial Sloan Kettering Cancer Center | 2013-02-01 |
| Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations (NCT01803750) | Memorial Sloan Kettering Cancer Center | 2013-02-01 |
| Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma (NCT01788839) | Memorial Sloan Kettering Cancer Center | 2013-02-01 |
| Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting (NCT01805609) | Memorial Sloan Kettering Cancer Center | 2013-02-01 |
| Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01767675) | Memorial Sloan Kettering Cancer Center | 2013-01-08 |
| Clinical and Histopathologic Characteristics of BAP1 Mutations (NCT01773655) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma (NCT01766739) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Group Interventions for Breast Cancer Survivors (NCT01775085) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer (NCT01791309) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis (NCT01757717) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Genomic Profiling in Cancer Patients (NCT01775072) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer (NCT01943695) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer (NCT01774071) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| Enoxaparin Versus Aspirin in Patients With Cancer and Stroke (NCT01763606) | Memorial Sloan Kettering Cancer Center | 2012-12-18 |
| 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy (NCT01751451) | Memorial Sloan Kettering Cancer Center | 2012-12-18 |
| Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma (NCT01758328) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections (NCT01749332) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma (NCT01755975) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma (NCT01745588) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (NCT01746849) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma (NCT01757626) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) (NCT01724606) | Memorial Sloan Kettering Cancer Center | 2012-11-05 |
| Functional Imaging of Cerebellar Mutism Syndrome (NCT01733173) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| Impact of ICCAN on Cancer Treatment Completion and Quality of Life (NCT01742143) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health (NCT01738152) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) (NCT01721525) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia (NCT01711632) | Memorial Sloan Kettering Cancer Center | 2012-10-01 |
| Acupuncture for Chronic Lymphedema (NCT01706081) | Memorial Sloan Kettering Cancer Center | 2012-10-01 |
| Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer (NCT01716247) | Memorial Sloan Kettering Cancer Center | 2012-10-01 |
| Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies (NCT01682226) | Memorial Sloan Kettering Cancer Center | 2012-09-05 |
| A Safety Study Assessing the Effects of Receiving Genome Sequencing Results (NCT01692223) | Memorial Sloan Kettering Cancer Center | 2012-09-01 |
| Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation (NCT01682213) | Memorial Sloan Kettering Cancer Center | 2012-09-01 |
| Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer (NCT01688492) | Memorial Sloan Kettering Cancer Center | 2012-09-01 |
| A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) (NCT01697930) | Memorial Sloan Kettering Cancer Center | 2012-09-01 |
| Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes (NCT01664936) | Memorial Sloan Kettering Cancer Center | 2012-08-08 |
| Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors (NCT01662804) | Memorial Sloan Kettering Cancer Center | 2012-08-06 |
| Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness (NCT01667952) | Memorial Sloan Kettering Cancer Center | 2012-08-01 |
| HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET (NCT01668173) | Memorial Sloan Kettering Cancer Center | 2012-08-01 |
| Use of a Video Decision Tool to Improve Informed Decision-Making in Hospitalized Patients Considering Palliative Radiation Therapy (NCT01667965) | Memorial Sloan Kettering Cancer Center | 2012-08-01 |
| Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation (NCT01646645) | Memorial Sloan Kettering Cancer Center | 2012-07-13 |
| Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) (NCT01642186) | Memorial Sloan Kettering Cancer Center | 2012-07-12 |
| Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity (NCT01639508) | Memorial Sloan Kettering Cancer Center | 2012-07-01 |
| MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk (NCT01649661) | Memorial Sloan Kettering Cancer Center | 2012-07-01 |
| 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain (NCT01621906) | Memorial Sloan Kettering Cancer Center | 2012-06-13 |
| Improving End of Life Care in Head and Neck Cancer (NCT01632969) | Memorial Sloan Kettering Cancer Center | 2012-06-01 |
| Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast Cancer (NCT01632956) | Memorial Sloan Kettering Cancer Center | 2012-06-01 |
| Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer (NCT01613521) | Memorial Sloan Kettering Cancer Center | 2012-06-01 |
| Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy (NCT01622660) | Memorial Sloan Kettering Cancer Center | 2012-06-01 |
| Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer (NCT01617174) | Memorial Sloan Kettering Cancer Center | 2012-06-01 |
| Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes (NCT01606787) | Memorial Sloan Kettering Cancer Center | 2012-05-22 |
| Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors (NCT01603004) | Memorial Sloan Kettering Cancer Center | 2012-05-14 |
| Food: A Three-Arm Study Examining Food Insecurity Interventions (NCT01603316) | Memorial Sloan Kettering Cancer Center | 2012-05-08 |
| Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation (NCT01596257) | Memorial Sloan Kettering Cancer Center | 2012-05-05 |
| Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor (NCT01598025) | Memorial Sloan Kettering Cancer Center | 2012-05-02 |
| A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression (NCT01604512) | Memorial Sloan Kettering Cancer Center | 2012-05-01 |
| Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer (NCT01591772) | Memorial Sloan Kettering Cancer Center | 2012-04-24 |
| Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers (NCT01579994) | Memorial Sloan Kettering Cancer Center | 2012-04-16 |
| Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) (NCT01579929) | Memorial Sloan Kettering Cancer Center | 2012-04-01 |
| Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma (NCT01582204) | Memorial Sloan Kettering Cancer Center | 2012-04-01 |
| Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection (NCT01596283) | Memorial Sloan Kettering Cancer Center | 2012-04-01 |
| Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer (NCT01589094) | Memorial Sloan Kettering Cancer Center | 2012-04-01 |
| Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer (NCT01558648) | Memorial Sloan Kettering Cancer Center | 2012-03-14 |
| Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma (NCT01558661) | Memorial Sloan Kettering Cancer Center | 2012-03-01 |
| Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer (NCT01522768) | Memorial Sloan Kettering Cancer Center | 2012-03-01 |
| Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium (NCT01551030) | Memorial Sloan Kettering Cancer Center | 2012-03-01 |
| Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer (NCT01542021) | Memorial Sloan Kettering Cancer Center | 2012-02-24 |
| Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer (NCT01543659) | Memorial Sloan Kettering Cancer Center | 2012-02-21 |
| Doctor-Patient Communication About Colorectal Cancer Screening (NCT01534923) | Memorial Sloan Kettering Cancer Center | 2012-02-07 |
| MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning (NCT01534104) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy (NCT01551433) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients (NCT02278003) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers (NCT01535898) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix) (NCT01532232) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |